Loading clinical trials...
Loading clinical trials...
Effect of Maolactin™ FMR Supplementation on Exercise Recovery, Inflammation, and Muscle Comfort in an Otherwise Healthy Population: A Double-blind Randomized Placebo-controlled Study
This is a double blind, randomised, placebo-controlled, parallel-group trial to evaluate the effect of Maolactin FMR supplementation on post exercise inflammation, exercise recovery and muscle fatigue and pain in an otherwise healthy population of adults 18-65 years old over 10 weeks with 8 weeks of supplementation. This is PART A of the study.
Age
18 - 65 years
Sex
ALL
Healthy Volunteers
Yes
RDC Clinical Pty Ltd
Brisbane, Queensland, Australia
Start Date
September 12, 2024
Primary Completion Date
May 23, 2025
Completion Date
May 23, 2025
Last Updated
June 25, 2025
33
ACTUAL participants
Maolactin
DRUG
Maltodextrin
DRUG
Lead Sponsor
RDC Clinical Pty Ltd
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05013255